Andrea Rubbert-Roth
Rheumatologie · Dept. I
Treatment of refractory subacute cuataneous lupus erythematosus with baricitinib
Joos L, Vetterli F, Jaeger T, Cozzio A, von Kempis J, Rubbert-Roth A. Treatment of refractory subacute cuataneous lupus erythematosus with baricitinib. Clin Exp Dermatol 2021
Nov 8, 2021Treatment of refractory subacute cuataneous lupus erythematosus with baricitinib
Nov 8, 2021Clin Exp Dermatol 2021
Joos L, Vetterli F, Jaeger T, Cozzio A, von Kempis Johannes, Rubbert-Roth Andrea
Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses
Schmiedeberg K, Vuilleumier N, Pagano S, Albrich W, Ludewig B, von Kempis J, Rubbert-Roth A. Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses. Lancet Rheumatol 2021; 4:e11-e13.
Oct 26, 2021Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses
Oct 26, 2021Lancet Rheumatol 2021; 4:e11-e13
Schmiedeberg Kristin, Vuilleumier Nicolas, Pagano Sabrina, Albrich Werner, Ludewig Burkhard, von Kempis Johannes, Rubbert-Roth Andrea
Successful Treatment of Rituximab-Associated Palmoplantar Pustulosis With Apremilast in a Patient With Seropositive Rheumatoid Arthritis
Haller C, Cozzio A, von Kempis J, Rubbert-Roth A. Successful Treatment of Rituximab-Associated Palmoplantar Pustulosis With Apremilast in a Patient With Seropositive Rheumatoid Arthritis. J Clin Rheumatol 2021; 27:e289-e290.
Oct 1, 2021Successful Treatment of Rituximab-Associated Palmoplantar Pustulosis With Apremilast in a Patient With Seropositive Rheumatoid Arthritis
Oct 1, 2021J Clin Rheumatol 2021; 27:e289-e290
Haller Christoph, Cozzio Antonio, von Kempis Johannes, Rubbert-Roth Andrea
Pausing drugs and spacing vaccines: an open question - Authors' reply
Rubbert-Roth A, Schmiedeberg K, von Kempis J. Pausing drugs and spacing vaccines: an open question - Authors' reply. Lancet Rheumatol 2021; 3:e683-e684.
Sep 22, 2021Pausing drugs and spacing vaccines: an open question - Authors' reply
Sep 22, 2021Lancet Rheumatol 2021; 3:e683-e684
Rubbert-Roth Andrea, Schmiedeberg Kristin, von Kempis Johannes
Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data
Rehberg M, Choy E, Rubbert-Roth A, Castañeda S, Schwarting A, Gottenberg J, Curtis J, Iglesias-Rodriguez M, van Hoogstraten H, Praestgaard A, Giegerich C, MOBILITY, MONARCH, TARGET, and ASCERTAIN investigators. Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data. Rheumatol Ther 2021; 8:1661-1675.
Sep 14, 2021Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data
Sep 14, 2021Rheumatol Ther 2021; 8:1661-1675
Rehberg Markus, Choy Ernest H S, Rubbert-Roth Andrea, Castañeda Santos, Schwarting Andreas, Gottenberg Jacques-Eric, Curtis Jeffrey R, Iglesias-Rodriguez Melitza, van Hoogstraten Hubert, Praestgaard Amy, Giegerich Clemens, MOBILITY, MONARCH, TARGET, and ASCERTAIN investigators
Cohort profile: SCREEN-RA: design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritis
Gilbert B, Moeller B, Kyburz D, Rubbert-Roth A, Courvoisier D, Studer O, Trunk E, Lauper K, Mongin D, Lamacchia C, Finckh A. Cohort profile: SCREEN-RA: design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritis. BMJ Open 2021; 11:e048409.
Jul 14, 2021Cohort profile: SCREEN-RA: design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritis
Jul 14, 2021BMJ Open 2021; 11:e048409
Gilbert Benoit Thomas P, Moeller Burkhard, Kyburz Diego, Rubbert-Roth Andrea, Courvoisier Delphine S, Studer Olivia, Trunk Eric, Lauper Kim, Mongin Denis, Lamacchia Céline, Finckh Axel
Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis
Rubbert-Roth A, Vuilleumier N, Ludewig B, Schmiedeberg K, Haller C, von Kempis J. Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis. Lancet Rheumatol 2021; 3:e470-e472.
Jun 8, 2021Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis
Jun 8, 2021Lancet Rheumatol 2021; 3:e470-e472
Rubbert-Roth Andrea, Vuilleumier Nicolas, Ludewig Burkhard, Schmiedeberg Kristin, Haller Christoph, von Kempis Johannes
Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis. Reply
Rubbert-Roth A, Xavier R. Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis. Reply. N Engl J Med 2021; 384:83-84.
Jan 7, 2021Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis. Reply
Jan 7, 2021N Engl J Med 2021; 384:83-84
Rubbert-Roth Andrea, Xavier Ricardo M
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)
Behrens F, Wassenberg S, Tony H, Rubbert-Roth A, Müller-Ladner U, Lehn A, Krueger K, Kellner H, Herrmann E, Feist E, Burmester G, Backhaus M, Aringer M, Alten R, Rossmanith T, Koehm M, Burkhardt H. Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study). Rheumatology (Oxford) 2021; 60:5318-5328.
Jan 3, 2021Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)
Jan 3, 2021Rheumatology (Oxford) 2021; 60:5318-5328
Behrens Frank, Wassenberg Siegfried, Tony Hans-Peter, Rubbert-Roth Andrea, Müller-Ladner Ulf, Lehn Annette, Krueger Klaus, Kellner Herbert, Herrmann Eva, Feist Eugen, Burmester Gerd R, Backhaus Marina, Aringer Martin, Alten Rieke, Rossmanith Tanja, Koehm Michaela, Burkhardt Harald
Associations between serum antibodies to periodontal pathogens and preclinical phases of rheumatoid arthritis
Manoil D, Courvoisier D, Gilbert B, Möller B, Walker U, Muehlenen I, Rubbert-Roth A, Finckh A, Bostanci N. Associations between serum antibodies to periodontal pathogens and preclinical phases of rheumatoid arthritis. Rheumatology (Oxford) 2021; 60:4755-4764.
Jan 2, 2021Associations between serum antibodies to periodontal pathogens and preclinical phases of rheumatoid arthritis
Jan 2, 2021Rheumatology (Oxford) 2021; 60:4755-4764
Manoil Daniel, Courvoisier Delphine S, Gilbert Benoit, Möller Burkhard, Walker Ulrich A, Muehlenen Ines Von, Rubbert-Roth Andrea, Finckh Axel, Bostanci Nagihan
Effect of disease duration and other characteristics on efficacy outcomes in clinical trials of tocilizumab for rheumatoid arthritis
Rubbert-Roth A, Aletaha D, Devenport J, Sidiropoulos P, Luder Y, Edwardes M, Jacobs J. Effect of disease duration and other characteristics on efficacy outcomes in clinical trials of tocilizumab for rheumatoid arthritis. Rheumatology (Oxford) 2021; 60:682-691.
Jan 1, 2021Effect of disease duration and other characteristics on efficacy outcomes in clinical trials of tocilizumab for rheumatoid arthritis
Jan 1, 2021Rheumatology (Oxford) 2021; 60:682-691
Rubbert-Roth Andrea, Aletaha Daniel, Devenport Jenny, Sidiropoulos Paris N, Luder Yves, Edwardes Michael D, Jacobs Johannes W G
Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools
Burmester G, Taylor P, Szekanecz Z, Stamm T, Rubbert-Roth A, Ramiro S, Østergaard M, Montecucco C, Iagnocco A, Gabay C, Ferreira R, Fautrel B, Durez P, Combe B, Calvo Alén J, Betteridge N, Álvaro-Gracia J, van de Laar M. Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools. Clin Exp Rheumatol 2020; 38:1056-1067.
Nov 17, 2020Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools
Nov 17, 2020Clin Exp Rheumatol 2020; 38:1056-1067
Burmester Gerd-Rüdiger, Taylor Peter C, Szekanecz Zoltán, Stamm Tanja, Rubbert-Roth Andrea, Ramiro Sofia, Østergaard Mikkel, Montecucco Carlomaurizio, Iagnocco Annamaria, Gabay Cem, Ferreira Ricardo J O, Fautrel Bruno, Durez Patrick, Combe Bernard, Calvo Alén Jaime, Betteridge Neil, Álvaro-Gracia José María, van de Laar Mart
Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort
Ciurea A, Scherer A, Distler O, Kyburz D, Dan D, Müller A, Bräm R, Andor M, Rubbert-Roth A, Möller B, Micheroli R, von Loga I, Bürki K, Papagiannoulis E, Finckh A. Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis 2020; 80:238-241.
Sep 22, 2020Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort
Sep 22, 2020Ann Rheum Dis 2020; 80:238-241
Ciurea Adrian, Scherer Almut, Distler Oliver, Kyburz Diego, Dan Diana, Müller Angela, Bräm René, Andor Michael, Rubbert-Roth Andrea, Möller Burkhard, Micheroli Raphael, von Loga Isabell, Bürki Kristina, Papagiannoulis Eleftherios, Finckh Axel
Diagnostische Herausforderungen bei einer Kleingefässvaskulitis
Rubbert-Roth A, Neumann T, Glaser-Gallion F. Diagnostische Herausforderungen bei einer Kleingefässvaskulitis. Swiss Med Forum 2020; 2020/3134:466-468.
Jul 29, 2020Diagnostische Herausforderungen bei einer Kleingefässvaskulitis
Jul 29, 2020Swiss Med Forum 2020; 2020/3134:466-468
Rubbert-Roth Andrea, Neumann Thomas, Glaser-Gallion Florian
Diagnostische Herausforderungen bei einem 54-jährigen Mann mit einer Kleingefässvaskulitis
Padberg Sgier B, Veraguth K, Median D, Niklaus M, Rubbert-Roth A, Glaser-Gallion F, Neumann T. Diagnostische Herausforderungen bei einem 54-jährigen Mann mit einer Kleingefässvaskulitis. Swiss Med Forum 2020; 20:466-468.
Jul 29, 2020Diagnostische Herausforderungen bei einem 54-jährigen Mann mit einer Kleingefässvaskulitis
Jul 29, 2020Swiss Med Forum 2020; 20:466-468
Padberg Sgier Barbara-Christina, Veraguth Katja, Median Daniela, Niklaus Monique, Rubbert-Roth Andrea, Glaser-Gallion Florian, Neumann Thomas
Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial
Kedor C, Specker C, Seipelt E, Schulze-Koops H, Rubbert-Roth A, Kekow J, Henes J, Blank N, Behrens F, Weiß A, Zernicke J, Listing J, Feist E. Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. Ann Rheum Dis 2020; 79:1090-1097.
May 13, 2020Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial
May 13, 2020Ann Rheum Dis 2020; 79:1090-1097
Kedor Claudia, Specker Christof, Seipelt Eva, Schulze-Koops Hendrik, Rubbert-Roth Andrea, Kekow Joern, Henes Joerg Christoph, Blank Norbert, Behrens Frank, Weiß Anja, Zernicke Jan, Listing Joachim, Feist Eugen
Tocilizumab in a patient with newly diagnosed rheumatoid arthritis secondary to checkpoint inhibitor therapy
Pirker I, Rubbert-Roth A, von Kempis J, Fehr M, Neumann T. Tocilizumab in a patient with newly diagnosed rheumatoid arthritis secondary to checkpoint inhibitor therapy. Clin Exp Rheumatol 2020
Jan 28, 2020Tocilizumab in a patient with newly diagnosed rheumatoid arthritis secondary to checkpoint inhibitor therapy
Jan 28, 2020Clin Exp Rheumatol 2020
Pirker Ian, Rubbert-Roth Andrea, von Kempis Johannes, Fehr Martin, Neumann Thomas
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
van der Heijde D, Mariette X, Li Z, Koloumas M, Huizinga T, Hetland M, Gottenberg J, Gossec L, Finckh A, Emery P, Müller-Ladner U, Mysler E, da Silva J, Westhovens R, Voshaar M, Takeuchi T, Strangfeld A, Saag K, Ruyssen-Witrand A, Rubbert-Roth A, Pope J, Poór G, van Eijk-Hustings Y, Edwards C, Cutolo M, de Wit M, van Vollenhoven R, Sepriano A, McInnes I, Kerschbaumer A, Dougados M, Burmester G, Bijlsma J, Landewé R, Aletaha D, Aringer M, Askling J, Codreanu C, De Cock D, Cardiel M, Caporali R, Buttgereit F, Buch M, den Broeder A, Boers M, Balsa A, Smolen J. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis 2020; 79:685-699.
Jan 22, 2020EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Jan 22, 2020Ann Rheum Dis 2020; 79:685-699
van der Heijde Désirée, Mariette Xavier, Li Zhanguo, Koloumas Marios, Huizinga Tom W J, Hetland Merete Lund, Gottenberg Jacques-Eric, Gossec Laure, Finckh Axel, Emery Paul, Müller-Ladner Ulf, Mysler Eduardo F, da Silva Jose A P, Westhovens René, Voshaar Marieke, Takeuchi Tsutomu, Strangfeld Anja, Saag Kenneth G, Ruyssen-Witrand Adeline, Rubbert-Roth Andrea, Pope Janet E, Poór Gyula, van Eijk-Hustings Yvonne, Edwards Christopher John, Cutolo Maurizio, de Wit Maarten, van Vollenhoven Ronald F, Sepriano Alexandre, McInnes Iain B, Kerschbaumer Andreas, Dougados Maxime, Burmester Gerd R, Bijlsma Johannes W J, Landewé Robert B M, Aletaha Daniel, Aringer Martin, Askling John, Codreanu Catalin, De Cock Diederik, Cardiel Mario Humberto, Caporali Roberto, Buttgereit Frank, Buch Maya H, den Broeder Alfons A, Boers Maarten, Balsa Alejandro, Smolen Josef S
Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis
Rubbert-Roth A, Enejosa J, Pangan A, Haraoui B, Rischmueller M, Khan N, Zhang Y, Martin N, Xavier R. Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis. N Engl J Med 2020; 383:1511-1521.
Jan 15, 2020Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis
Jan 15, 2020N Engl J Med 2020; 383:1511-1521
Rubbert-Roth Andrea, Enejosa Jeffrey, Pangan Aileen L, Haraoui Boulos, Rischmueller Maureen, Khan Nasser, Zhang Ying, Martin Naomi, Xavier Ricardo M
Should we combine biologics with methotrexate in axial spondyloarthritis?
Poddubnyy D, Amital H, Rubbert-Roth A. Should we combine biologics with methotrexate in axial spondyloarthritis?. Autoimmun Rev 2019; 18:102402.
Oct 24, 2019Should we combine biologics with methotrexate in axial spondyloarthritis?
Oct 24, 2019Autoimmun Rev 2019; 18:102402
Poddubnyy Denis, Amital Howard, Rubbert-Roth Andrea